Chapter
Exploring Psychedelics: From Mechanistic Level to Clinical Trials
Dr. Roland Griffiths, a pioneer in psychedelic research, shares insights on the growing interest in exploring psychedelics at the mechanistic level and the potential for participation in clinical trials for conditions like trauma, PTSD, and depression.
Clips
R01 grants are crucial for funding academic research and paying salaries, and failing to secure them can lead to the loss of a job or reduced support.
2:39:52 - 2:40:41 (00:48)
Summary
R01 grants are crucial for funding academic research and paying salaries, and failing to secure them can lead to the loss of a job or reduced support.
ChapterExploring Psychedelics: From Mechanistic Level to Clinical Trials
EpisodeDr. Matthew Johnson: Psychedelics for Treating Mental Disorders
PodcastHuberman Lab
Dr. Matthew Johnson talks about the pioneering work done at Hopkins regarding psychedelics and the potential ways people can contact and participate in clinical trials.
2:40:41 - 2:46:06 (05:24)
Summary
Dr. Matthew Johnson talks about the pioneering work done at Hopkins regarding psychedelics and the potential ways people can contact and participate in clinical trials. He also shares his thoughts on the positive impact of his work and how social media has helped disseminate information on this topic.
ChapterExploring Psychedelics: From Mechanistic Level to Clinical Trials
EpisodeDr. Matthew Johnson: Psychedelics for Treating Mental Disorders
PodcastHuberman Lab
Learn how to participate in psychedelic studies at John Hopkins by visiting their website and signing up through the correct portal.
2:46:06 - 2:46:46 (00:40)
Summary
Learn how to participate in psychedelic studies at John Hopkins by visiting their website and signing up through the correct portal.